Arterial Blood Gas Kits Market is expected to reach US$ 1,213.05 million by 2030

Publisher: The Insight Partners

Non-Vented Segment, by Type, to Lead Global Arterial Blood Gas Kits Market During 2022–2030

According to our new research study on “Arterial Blood Gas Kits Market Forecast to 2030 – COVID-19 Impact and Global Analysis – by Product, Type, Usage, Application, Needle Gauge, Syringe Volume, and End User,” the arterial blood gas kits market size was valued at US$ 695.67 million in 2022 and is expected to reach US$ 1,213.05 million by 2030; it is estimated to register a CAGR of 7.2% from 2022 to 2030. Key factors driving the arterial blood gas kits market growth include the increasing prevalence of respiratory diseases and the growing prevalence of metabolic and kidney diseases.

Based on type, the arterial blood gas kits market is segmented into non-vented and vented. The non-vented segment held a larger share of the market in 2022 and is anticipated to register a higher CAGR in the arterial blood gas kits market during the forecast period. Non-vented arterial blood gas kits do not have a vent or specialized mechanism to release air or excess pressure during the collection process. The kits eliminate the risk of air contamination, ensuring accurate ABG results. Non-vented kits also simplify the sample handling process by eliminating the need to expel air bubbles. They enhance safety for healthcare professionals by reducing the risk of accidental needlestick injuries, as there is no exposed needle or port. Due to these advantages, non-vented kits have gained popularity. The kits are typically used when smaller arterial blood samples are collected for immediate analysis. They are also demanded in situations where air contamination must be minimized, such as when measuring certain blood gas parameters, including oxygen (pO2) levels.

Arterial Blood Gas Kits Market, by Region, 2022(%)

To get free sample copy of the report, along with the TOC, Statistics, and Tables please visit @ https://www.theinsightpartners.com/sample/TIPRE00012482 Source: The Insight Partners Analysis

North America accounted for the largest share of the global arterial blood gas kits market in 2022. In the region, the US held the largest arterial blood gas kits market share and is anticipated to register the highest CAGR during the forecast period. The market in the country is growing owing to increase in the prevalence of heart diseases and respiratory diseases and a rise in comprehensive clinical research and contract research. According to the Asthma and Allergy Foundation of America, ~26 million people in the US had asthma in 2022, one of the world's most common respiratory diseases. Respiratory infections cause more severe disease, hospitalizations, and death in older persons than in younger ones due to age-related issues such as frailty. Asthma is one of the most common respiratory diseases among senior citizens. According to the 2020 Census, the geriatric population reached 55.8 million (16.8%) of the population of the US in 2020. The population of people aged 65 and above is predicted to increase between 2012 and 2050. This growth needs a greater understanding of the impacts of respiratory diseases on older adults, as patients suffering from respiratory disorders usually experience breathing issues due to oxygen shortage. Arterial blood gas (ABG) test is carried out to measure the amount of oxygen and carbon dioxide dissolved in the arterial blood of patients. Thus, the above-mentioned factors propel the need for ABG tests, which fuels the arterial blood gas kits market growth.

Radiometer Medical ApS; Vyaire Medical Inc; Opti Medical Systems; ITL Health Group Ltd; Teleflex Inc; Becton Dickinson and Co; ICU Medical Inc; SunMed LLC; Trudell Healthcare Solutions Inc; Siemens Healthineers AG; Medline Industries LP; Cardinal Health Inc; and Fisher Scientific International, Inc are among the leading companies operating in the arterial blood gas kits market.  

Based on product, the arterial blood gas kits market is segmented into Luer Lock syringe and Luer Slip syringe. In terms of type, the arterial blood gas kits market is segmented into non-vented and vented. The arterial blood gas kits market, by usage, is bifurcated into pre-set plunger mode and manual aspiration. Based on application, the arterial blood gas kits market is segmented into in vitro diagnostics, electrolyte analysis, and pH blood gas. By needle gauge, the arterial blood gas kits market is segmented into 23G to 25G and less than 23G. In terms of syringe volume, the arterial blood gas kits market is segmented into 1 ml, 3 ml, and others. Based on end user, the arterial blood gas kits market is segmented into hospitals, clinics , and others. By geography, the arterial blood gas kits market is segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, the UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, and the Rest of APAC), the Middle East & Africa (Saudi Arabia, the UAE, South Africa, and the Rest of MEA), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

Contact Us
Contact Us: The Insight Partners 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com